Citadel Advisors »

Regulus Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $58k 45k 1.28
2023-09-30 $41k 29k 1.38
2023-06-30 $72k 49k 1.47
2023-03-31 $16k 19k 0.85
2022-12-31 $88k 64k 1.37
2022-06-30 $49k 24k 2.07